Stereotactic Body Radiation Therapy in Recurrent Hepatocellular Carcinoma
Authors:
- Yee-Min JenYJYee-Min Jen
- Meei-Shyuan LeeMLMeei-Shyuan Lee
- Li-Ping ChangLCLi-Ping Chang
- Chang-Ming ChenCCChang-Ming Chen
- Kai-Hsiung KoKKKai-Hsiung Ko
- Kuen-Tze LinKLKuen-Tze Lin
- Jang-Chun LinJLJang-Chun Lin
- Hsing-Lung ChaoHCHsing-Lung Chao
- Chun-Shu LinCLChun-Shu Lin
- Yu-Fu SuYSYu-Fu Su
- Chao-Yueh FanCFChao-Yueh Fan
- 1 October 2012
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 84 (2) , 355-361
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary ResultsTechnology in Cancer Research & Treatment, 2010
- Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its useJournal of Gastroenterology and Hepatology, 2010
- Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysisBMC Cancer, 2008
- Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaJournal of Clinical Oncology, 2008
- Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic FactorsAnnals of Surgical Oncology, 2007
- Fractionated Stereotactic Radiotherapy in Patients with Primary Hepatocellular CarcinomaJapanese Journal of Clinical Oncology, 2006
- Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii studyActa Oncologica, 2006
- Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomyBritish Journal of Surgery, 2005
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002